Skip to main content
Top
Published in: BMC Infectious Diseases 1/2001

Open Access 01-12-2001 | Research article

Blood borne transit of CJD from brain to gut at early stages of infection

Authors: Klaus Radebold, Mark Chernyak, Daniel Martin, Laura Manuelidis

Published in: BMC Infectious Diseases | Issue 1/2001

Login to get access

Abstract

Background

In Creutzfeldt-Jakob disease (CJD) and other related transmissible spongiform encephalopathies it is critical to understand the various pathways by which the infectious agent spreads to different organs.

Methods

We injected a CJD agent into mice, either intracerebrally (ic) or intraperitoneally (ip) and monitored the progressive appearance of abnormal PrP in peripheral tissues over time.

Results

Abnormal PrP was detected in lymphoreticular tissues of the gastrointestinal tract as early as 28 to 32 days after infection by both routes. This change persisted until the terminal stages of disease. In contrast, abnormal PrP was not detected in brain or spinal cord until 80 to 120 days after ic inoculation, or until 170 days after ip inoculation.

Conclusions

Brain lacks significant lymphatic drainage, and has little infectivity before 40 days, even after ic inoculation. Thus the infectious inoculum must spread to the gut by a vascular route, a direction opposite to that generally assumed. This interpretation is consistent with previous studies demonstrating white blood cell infectivity as well as perivascular PrP accumulations in CJD. Notably, enteric infection at early as well as later stages of disease, and regardless of the route of agent entry, implicates potential environmental spread by fecal matter.
Appendix
Available only for authorised users
Literature
1.
go back to reference Manuelidis L, Fritch W, Xi YG: Evolution of a strain of CJD that induces BSE-like plaques. Science. 1997, 277: 94-98. 10.1126/science.277.5322.94.CrossRefPubMed Manuelidis L, Fritch W, Xi YG: Evolution of a strain of CJD that induces BSE-like plaques. Science. 1997, 277: 94-98. 10.1126/science.277.5322.94.CrossRefPubMed
2.
go back to reference Bons N, Mestre-Frances N, Belli P, et al: Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci USA. 1999, 96: 4046-4051. 10.1073/pnas.96.7.4046.CrossRefPubMedPubMedCentral Bons N, Mestre-Frances N, Belli P, et al: Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci USA. 1999, 96: 4046-4051. 10.1073/pnas.96.7.4046.CrossRefPubMedPubMedCentral
3.
go back to reference Kimberlin RH, Walker CA: Pathogenesis of scrapie in mice after intragastric infection. Virus Res. 1989, 12: 213-220. 10.1016/0168-1702(89)90040-3.CrossRefPubMed Kimberlin RH, Walker CA: Pathogenesis of scrapie in mice after intragastric infection. Virus Res. 1989, 12: 213-220. 10.1016/0168-1702(89)90040-3.CrossRefPubMed
4.
go back to reference Baldauf E, Beekes M, Diringer H: Evidence for an alternative direct route of access for the scrapie agent to the brain bypassing the spinal cord. J Gen Virol. 1997, 78: 1187-97.CrossRefPubMed Baldauf E, Beekes M, Diringer H: Evidence for an alternative direct route of access for the scrapie agent to the brain bypassing the spinal cord. J Gen Virol. 1997, 78: 1187-97.CrossRefPubMed
5.
go back to reference Muramoto T, Kitamoto T, Tateishi J, Goto I: Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jacob disease via intraperitoneal route: a sequential study. Am J Pathol. 1993, 143: 1470-1479.PubMedPubMedCentral Muramoto T, Kitamoto T, Tateishi J, Goto I: Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jacob disease via intraperitoneal route: a sequential study. Am J Pathol. 1993, 143: 1470-1479.PubMedPubMedCentral
6.
go back to reference Shiomchik MJ, Radebold K, Duclos N, Manuelidis L: Neuroinvasion by a Creutzfeldt-Jakob disease agent in the absence of B cells and follicular dendritic cells:. Proc Natl Acad Sci. 2001, 98: 9289-9294. 10.1073/pnas.161055198.CrossRef Shiomchik MJ, Radebold K, Duclos N, Manuelidis L: Neuroinvasion by a Creutzfeldt-Jakob disease agent in the absence of B cells and follicular dendritic cells:. Proc Natl Acad Sci. 2001, 98: 9289-9294. 10.1073/pnas.161055198.CrossRef
7.
go back to reference Baker CA, Lu ZY, Zaitsev I, Manuelidis L: Microglial activation varies in different models of Creutzfeldt-Jakob disease. J Virol. 1999, 73: 5089-5097.PubMedPubMedCentral Baker CA, Lu ZY, Zaitsev I, Manuelidis L: Microglial activation varies in different models of Creutzfeldt-Jakob disease. J Virol. 1999, 73: 5089-5097.PubMedPubMedCentral
8.
go back to reference Manuelidis L, Zaitsev I, Koni P, Lu ZY, Flavell RA, Fritch W: Follicular dendritic cells and dissemination of Creutzfeldt-Jacob disease. J Virol. 2000, 74: 8614-8622. 10.1128/JVI.74.18.8614-8622.2000.CrossRefPubMedPubMedCentral Manuelidis L, Zaitsev I, Koni P, Lu ZY, Flavell RA, Fritch W: Follicular dendritic cells and dissemination of Creutzfeldt-Jacob disease. J Virol. 2000, 74: 8614-8622. 10.1128/JVI.74.18.8614-8622.2000.CrossRefPubMedPubMedCentral
9.
go back to reference Manuelidis L, Fritch W: Infectivity and host responses in Creutzfeldt-Jakob disease. Virology. 1996, 216: 46-59. 10.1006/viro.1996.0033.CrossRefPubMed Manuelidis L, Fritch W: Infectivity and host responses in Creutzfeldt-Jakob disease. Virology. 1996, 216: 46-59. 10.1006/viro.1996.0033.CrossRefPubMed
10.
go back to reference Manuelidis L: Beneath the emperor's clothes: The body of data in scrapie and CJD. Annales de L'Institut Pasteur. 1997, 8 (4): 311-326. 10.1016/S0924-4204(97)86597-3.CrossRef Manuelidis L: Beneath the emperor's clothes: The body of data in scrapie and CJD. Annales de L'Institut Pasteur. 1997, 8 (4): 311-326. 10.1016/S0924-4204(97)86597-3.CrossRef
11.
go back to reference Manuelidis EE, Gorgacz EJ, Manuelidis L: Viremia in experimental Creutzfeldt-Jacob disease. Science. 1978, 200: 1069-1071.CrossRefPubMed Manuelidis EE, Gorgacz EJ, Manuelidis L: Viremia in experimental Creutzfeldt-Jacob disease. Science. 1978, 200: 1069-1071.CrossRefPubMed
12.
go back to reference Manuelidis EE, Kim JH, Mericangas JR, Manuelidis L: Transmission to animals of Creutzfeldt-Jacob disease from human blood. Lancet. 1985, ii: 896-897. 10.1016/S0140-6736(85)90165-5.CrossRef Manuelidis EE, Kim JH, Mericangas JR, Manuelidis L: Transmission to animals of Creutzfeldt-Jacob disease from human blood. Lancet. 1985, ii: 896-897. 10.1016/S0140-6736(85)90165-5.CrossRef
13.
go back to reference Raeber AJ, Klein MA, Frigg R, Flechsig E, Aguzzi A, Weissmami C: PrP-dependent association of prions with splenic but not circulating lymphocytes of scrapie-infected mice. EMBO J. 1999, 18: 2702-2706. 10.1093/emboj/18.10.2702.CrossRefPubMedPubMedCentral Raeber AJ, Klein MA, Frigg R, Flechsig E, Aguzzi A, Weissmami C: PrP-dependent association of prions with splenic but not circulating lymphocytes of scrapie-infected mice. EMBO J. 1999, 18: 2702-2706. 10.1093/emboj/18.10.2702.CrossRefPubMedPubMedCentral
14.
go back to reference Brown P, Rowher RG, Dunstan BS, MacAuley C, Gadjusek DC, Drohan WN: The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion. 1998, 38: 810-816. 10.1046/j.1537-2995.1998.38998408999.x.CrossRefPubMed Brown P, Rowher RG, Dunstan BS, MacAuley C, Gadjusek DC, Drohan WN: The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion. 1998, 38: 810-816. 10.1046/j.1537-2995.1998.38998408999.x.CrossRefPubMed
15.
go back to reference Ingrosso L, Pisani F, Pocchiari M: Transmission of the 263K scrapie strain by the dental route. J Gen Virol. 1999, 80: 3043-3047.CrossRefPubMed Ingrosso L, Pisani F, Pocchiari M: Transmission of the 263K scrapie strain by the dental route. J Gen Virol. 1999, 80: 3043-3047.CrossRefPubMed
16.
go back to reference Houston F, Foster JD, Chong A, Hunter N, Bostock CJ: Transmission of BSE by blood transfusion in sheep. Lancet. 2000, 356: 999-1000. 10.1016/S0140-6736(00)02719-7.CrossRefPubMed Houston F, Foster JD, Chong A, Hunter N, Bostock CJ: Transmission of BSE by blood transfusion in sheep. Lancet. 2000, 356: 999-1000. 10.1016/S0140-6736(00)02719-7.CrossRefPubMed
17.
go back to reference Brown P, Cervenakova L, Diringer H: Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jacob disease. J Lab Clin Med. 2001, 137: 5-13. 10.1067/mlc.2001.111951.CrossRefPubMed Brown P, Cervenakova L, Diringer H: Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jacob disease. J Lab Clin Med. 2001, 137: 5-13. 10.1067/mlc.2001.111951.CrossRefPubMed
Metadata
Title
Blood borne transit of CJD from brain to gut at early stages of infection
Authors
Klaus Radebold
Mark Chernyak
Daniel Martin
Laura Manuelidis
Publication date
01-12-2001
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2001
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-1-20

Other articles of this Issue 1/2001

BMC Infectious Diseases 1/2001 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine